The operation of the new plant will involve a joint venture between the Premium International Injectable Company (Pvt) Ltd, a subsidiary of Raddella Holdings and the State Pharmaceutical Manufacturing Corporation (SPMC). All new products manufactured as a result of this venture will be done under the SPMC brand name, with full government supervision.
The new plant will utilize world famous SCADA systems to monitor and control the plant, all equipment, and the entire manufacturing process. This will guarantee the highest level of quality control, where all records of manufacture are completely automated and thus tamper-proof. Other quality control methods include adhering to The European Union Goods Manufacturing Practice (EUGMP), Good Manufacturing Practice (GMP), while also complying with the strict standards set by the World Health Organization (WHO).
The extensive planning for the plant happened over the last two years, in this time all designs, technology transfers, and specialist training have been completed, with all approvals and certification having been obtained. With construction completed soon, the plant will commence operations shortly.
